Adhd
Adhd
Hyperactivity Disorder
(ADHD)
Contents
What is attention deficit hyperactivity disorder?__________________________ 1
What are the symptoms of ADHD in children?____________________________ 2
What causes ADHD?_ _________________________________________________ 3
How is ADHD diagnosed?______________________________________________ 5
How is ADHD treated?_________________________________________________ 7
Medications_______________________________________________________ 7
Psychotherapy ___________________________________________________ 10
Medications
The most common type of medication used for treating ADHD
is called a stimulant. Although it may seem unusual to treat
ADHD with a medication considered a stimulant, it actually has
a calming effect on children with ADHD. Many types of stimulant
medications are available. A few other ADHD medications are
non-stimulants and work differently than stimulants. For many
children, ADHD medications reduce hyperactivity and impulsivity
and improve their ability to focus, work, and learn. Medication also may improve
physical coordination.
However, a one-size-fits-all approach does not apply for all children with ADHD.
What works for one child might not work for another. One child might have side
effects with a certain medication, while another child may not. Sometimes several
different medications or dosages must be tried before finding one that works for a
particular child. Any child taking medications must be monitored closely and carefully by caregivers and doctors.
Stimulant medications come in different forms, such as a pill, capsule, liquid, or
skin patch. Some medications also come in short-acting, long-acting, or extended
release varieties. In each of these varieties, the active ingredient is the same, but
it is released differently in the body. Long-acting or extended release forms often
allow a child to take the medication just once a day before school, so they dont
have to make a daily trip to the school nurse for another dose. Parents and doctors
should decide together which medication is best for the child and whether the child
needs medication only for school hours or for evenings and weekends, too.
A list of medications and the approved age for use follows. ADHD can be diagnosed
and medications prescribed by M.D.s (usually a psychiatrist) and in some states
also by clinical psychologists, psychiatric nurse practitioners, and advanced
psychiatric nurse specialists. Check with your states licensing agency for specifics.
Generic Name
Approved Age
Adderall
amphetamine
3 and older
Adderall XR
6 and older
Concerta
6 and older
Daytrana
methylphenidate patch
6 and older
Desoxyn
methamphetamine hydrochloride
6 and older
Dexedrine
dextroamphetamine
3 and older
Dextrostat
dextroamphetamine
3 and older
Focalin
dexmethylphenidate
6 and older
Focalin XR
6 and older
Metadate ER
6 and older
Metadate CD
6 and older
Methylin
6 and older
Ritalin
methylphenidate
6 and older
Ritalin SR
6 and older
Ritalin LA
6 and older
Strattera
atomoxetine
6 and older
Vyvanse
lisdexamfetamine dimesylate
6 and older
Over time, this list will grow, as researchers continue to develop new medications
for ADHD. Medication guides for each of these medications are available from
the U.S. Food and Drug Administration (FDA) at http://www.fda.gov/cder/drug/
infopage/ADHD/default.htm.
concerns about your childs growth or weight gain while he or she is taking this
medication.
Sleep problems. If a child cannot fall asleep, the doctor may prescribe a lower
dose of the medication or a shorter-acting form. The doctor might also suggest
giving the medication earlier in the day, or stopping the afternoon or evening
dose. Adding a prescription for a low dose of an antidepressant or a blood
pressure medication called clonidine sometimes helps with sleep problems.
A consistent sleep routine that includes relaxing elements like warm milk, soft
music, or quiet activities in dim light, may also help.
Less common side effects. A few children develop sudden, repetitive movements or sounds called tics. These tics may or may not be noticeable. Changing
the medication dosage may make tics go away. Some children also may have a
personality change, such as appearing flat or without emotion. Talk with your
childs doctor if you see any of these side effects.
likely to have suicidal thoughts than children and teenagers with ADHD who do not
take it. If your child is taking atomoxetine, watch his or her behavior carefully.
A child may develop serious symptoms suddenly, so it is important to pay
attention to your childs behavior every day. Ask other people who spend a lot of
time with your child to tell you if they notice changes in your childs behavior. Call
a doctor right away if your child shows any unusual behavior. While taking atomoxetine, your child should see a doctor often, especially at the beginning of treatment, and be sure that your child keeps all appointments with his or her doctor.
Psychotherapy
Different types of psychotherapy are used for ADHD. Behavioral therapy aims to
help a child change his or her behavior. It might involve practical assistance, such
as help organizing tasks or completing schoolwork, or working through emotionally difficult events. Behavioral therapy also teaches a child how to monitor his or
her own behavior. Learning to give oneself praise or rewards for acting in a desired
way, such as controlling anger or thinking before acting, is another goal of behavioral therapy. Parents and teachers also can give positive or negative feedback for
certain behaviors. In addition, clear rules, chore lists, and other structured routines
can help a child control his or her behavior.
Therapists may teach children social skills, such as how to wait their turn, share
toys, ask for help, or respond to teasing. Learning to read facial expressions and
the tone of voice in others, and how to respond appropriately can also be part of
social skills training.
ADHD also may coexist with a sleep disorder, bed-wetting, substance abuse, or
other disorders or illnesses.
For more information on these disorders, visit http://www.nimh.nih.gov/health/
topics/index.shtml.
Recognizing ADHD symptoms and seeking help early will lead to better outcomes
for both affected children and their families.
More information about Department of Education programs for children with disabilities is available at http://www.ed.gov/parents/needs/speced/edpicks.jhtml?src=ln.
Transitions can be difficult. Each school year brings a new teacher and new
schoolwork, a change that can be especially hard for a child with ADHD who
needs routine and structure. Consider telling the teachers that your child has
ADHD when he or she starts school or moves to a new class. Additional support
will help your child deal with the transition.
To help them stay healthy and provide needed structure, teens with ADHD should
be given rules that are clear and easy to understand. Helping them stay focused
and organizedsuch as posting a chart listing household chores and responsibilities with spaces to check off completed itemsalso may help.
Teens with or without ADHD want to be independent and try
new things, and sometimes they will break rules. If your teen
breaks rules, your response should be as calm and matter-offact as possible. Punishment should be used only rarely. Teens
with ADHD often have trouble controlling their impulsivity and
tempers can flare. Sometimes, a short time-out can be calming.
If your teen asks for later curfews and use of the car, listen to
the request, give reasons for your opinions, and listen to your
childs opinion. Rules should be clear once they are set, but communication,
negotiation, and compromise are helpful along the way. Maintaining treatments,
such as medication and behavioral or family therapy, also can help with managing
your teenagers ADHD.
Citations
1 DSM-IV-TR workgroup. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,
Text Revision. Washington, DC: American Psychiatric Association.
2 Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular
genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 2005; 57:1313-1323.
3 Khan SA, Faraone SV. The genetics of attention-deficit/hyperactivity disorder: A literature review of
2005. Current Psychiatry Reports, 2006 Oct; 8:393-397.
4 Shaw P, Gornick M, Lerch J, Addington A, Seal J, Greenstein D, Sharp W, Evans A, Giedd JN,
Castellanos FX, Rapoport JL. Polymorphisms of the dopamine D4 receptor, clinical outcome and
cortical structure in attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 2007
Aug; 64(8):921-931.
5 Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I,
Thomsen PH, Olsen J, Jarvelin MR. Maternal lifestyle factors in pregnancy risk of attention-deficit/
hyperactivity disorder and associated behaviors: review of the current evidence. American Journal
of Psychiatry, 2003 Jun; 160(6):1028-1040.
6 Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit
hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal
of the American Academy of Child and Adolescent Psychiatry, 2002 Apr; 41(4):378-385.
7 Braun J, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and
attention-deficit/hyperactivity disorder in U.S. children. Environmental Health Perspectives, 2006
Dec; 114(12):1904-1909.
8 Wolraich M, Milich R, Stumbo P, Schultz F. The effects of sucrose ingestion on the behavior of
hyperactive boys. Pediatrics, 1985 Apr; 106(4):657-682.
9 Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets
high in sucrose or aspartame on the behavior and cognitive performance of children. New
England Journal of Medicine, 1994 Feb 3; 330(5):301-307.
10 Hoover DW, Milich R. Effects of sugar ingestion expectancies on mother-child interaction. Journal
of Abnormal Child Psychology, 1994; 22:501-515.
11 McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok E, Porteous L,
Prince E, Sonuga-Barke E, Warner JO. Stevenson J. Food additives and hyperactive behaviour in
3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebocontrolled trial. Lancet, 2007 Nov 3; 370(9598):1560-1567.
12 The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for
attention-deficit hyperactivity disorder. Archives of General Psychiatry, 1999; 56:1073-1086.
13 Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Relative benefits of stimulant
therapy with OROS methylphenidate versus mixed amphetamine salts extended release in
improving the driving performance of adolescent drivers with attention-deficit/hyperactivity
disorder. Pediatrics, 2006 Sept; 118(3):e704-e710.
Reprints:
This publication is in the public domain and may be reproduced or copied without
permission from NIMH. We encourage you to reproduce it and use it in your efforts
to improve public health. Citation of the National Institute of Mental Health as a
source is appreciated. However, using government materials inappropriately can
raise legal or ethical concerns, so we ask you to use these guidelines:
NIMH does not endorse or recommend any commercial products, processes, or
services, and our publications may not be used for advertising or endorsement
purposes.
NIMH does not provide specific medical advice or treatment recommendations
or referrals; our materials may not be used in a manner that has the appearance
of such information.
NIMH requests that non-Federal organizations not alter our publications in ways
that will jeopardize the integrity and brand when using the publication.
Addition of non-Federal Government logos and Web site links may not have
the appearance of NIMH endorsement of any specific commercial products or
services or medical treatments or services.
If you have questions regarding these guidelines and use of NIMH publications,
please contact the NIMH Information Center at 18666156464 or e-mail at
[email protected].
The photos in this publication are of models and are used for illustrative purposes only.